AzTrials
AzTrials

ObesityNCT02070081

Weight Loss Following Gastric Bypass or Sleeve Surgery

A study testing Roux-en-Y gastric bypass surgery or sleeve surgery in people with Obesity, run by University of Copenhagen at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall aim is to study the multiple factors determining the variation of weight loss after Roux-en-Y Gastric Bypass (RYGB) and Sleeve surgery. The specific aims are to evaluate: a) what explains the large individual differences in weight loss seen after RYGB and Sleeve surgery, b) if it is possible… Read more about this study

Who is it for?
Ages 25 to 65 years
Conditions the study is for
Obesity
What is being tested?
Roux-en-Y gastric bypass surgery or sleeve surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteDenmark
Study dates
Mar 2014to Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All patients approved for bariatric surgery at Bariatric Clinic, Køge Hospital, Denmark

Who cannot join

  • Inability to comply with the study protocol

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Faculty of Science, NEXS

    Frederiksberg, 1958

Other trials in Denmark

About this study

Official title: Patient Profiling for Successful Weight Loss After Gastric Bypass or Sleeve Surgery

The overall aim is to study the multiple factors determining the variation of weight loss after Roux-en-Y Gastric Bypass (RYGB) and Sleeve surgery.

The specific aims are to evaluate:

  1. what explains the large individual differences in weight loss seen after RYGB and Sleeve surgery, b) if it is possible pre-operatively to identify which patients will not obtain beneficial effects of bariatric surgery in relation to weight loss and quality of life and c) if patients in need of improved care can be identified pre- and/or early post-operatively.
Conditions
Obesity
Being tested
Roux-en-Y gastric bypass surgery or sleeve surgery
Keywords
Obesity, Bariatric surgery
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Roux-en-Y gastric bypass surgery or sleeve surgeryProcedure or surgery

Study groups in NCT02070081
Study groupRoleWhat they receive
SurgeryExperimentalNot described
Receives: Procedure: Roux-en-Y gastric bypass surgery or sleeve surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight loss

    Measured: 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively

Secondary outcomes (14)
  1. Metabolic profile

    Insulin, glucose, C-peptide, GIP, glucagon, TSH, thyroid hormones, vitamin D and blood lipids

    Measured: 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively

  2. Physical activity

    Measured: 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively

  3. Appetite sensation

    Following a test meal with the use of visual analogue scales (VAS)

    Measured: 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively

  4. Taste preferences and taste perception

    Sensory tests, picture displays (all visits) and an ad libitum test meals (3 months preoperatively and 6 months postoperatively) are used to investigate changes in taste and food preferences (liking and wanting) and taste perception

    Measured: 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively

  5. Mental health

    Measured: 3 month preoperatively, 6 month postoperatively and 18 month postoperatively

  6. Social resources

    Measured: 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively

  7. Gut microbiota

    Measured: 1 week preoperatively, 6 month postoperatively

  8. Appetite-regulating hormones

    GLP-1, PYY, leptin, ghrelin, OXM, CCK, glicentin

    Measured: 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively

  9. Bile acids and fibroblast growth factors

    Measured: 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively

  10. Genetics

    Measured: 3 month preoperatively

  11. Body composition

    By DXA scans

    Measured: 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively

  12. Cortisol

    Measured in hair

    Measured: 3 month preoperatively and 18 month postoperatively

  13. Neural activity in reward-processing brain centers

    By functional magnetic resonance imaging (fmri)

    Measured: preoperatively and 6 month postoperatively

  14. Rewarding value of food

    Behavioral test

    Measured: preoperatively and 6 month postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionApr 2017
  4. Study completionApr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02070081
Sponsor's protocol ID
GO Bypass
Status last verified
May 2019
First submitted
18 Feb 2014
Last updated
24 May 2019
Results posted
No
Data monitoring committee
No

Publications

  • Nielsen MS, Ritz C, Wewer Albrechtsen NJ, Holst JJ, le Roux CW, Sjodin A. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss. J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgaa061. doi: 10.1210/clinem/dgaa061.

    PubMed 32016415
  • Nielsen MS, Andersen INSK, Lange B, Ritz C, le Roux CW, Schmidt JB, Sjodin A, Bredie WLP. Bariatric Surgery Leads to Short-Term Effects on Sweet Taste Sensitivity and Hedonic Evaluation of Fatty Food Stimuli. Obesity (Silver Spring). 2019 Nov;27(11):1796-1804. doi: 10.1002/oby.22589. Epub 2019 Sep 26.

    PubMed 31556242
  • Taekker L, Lunn S. The effect of mental health on weight loss after bariatric surgery. Dan Med J. 2019 Feb;66(2):A5532.

    PubMed 30722827
  • Sondergaard Nielsen M, Rasmussen S, Just Christensen B, Ritz C, le Roux CW, Berg Schmidt J, Sjodin A. Bariatric Surgery Does Not Affect Food Preferences, but Individual Changes in Food Preferences May Predict Weight Loss. Obesity (Silver Spring). 2018 Dec;26(12):1879-1887. doi: 10.1002/oby.22272. Epub 2018 Nov 13.

    PubMed 30421858
  • Christensen BJ, Schmidt JB, Nielsen MS, Taekker L, Holm L, Lunn S, Bredie WLP, Ritz C, Holst JJ, Hansen T, Hilbert A, le Roux CW, Hulme OJ, Siebner H, Morville T, Naver L, Floyd AK, Sjodin A. Patient profiling for success after weight loss surgery (GO Bypass study): An interdisciplinary study protocol. Contemp Clin Trials Commun. 2018 Feb 17;10:121-130. doi: 10.1016/j.conctc.2018.02.002. eCollection 2018 Jun.

    PubMed 30023446
  • Nielsen MS, Christensen BJ, Ritz C, Rasmussen S, Hansen TT, Bredie WLP, le Roux CW, Sjodin A, Schmidt JB. Roux-En-Y Gastric Bypass and Sleeve Gastrectomy Does Not Affect Food Preferences When Assessed by an Ad libitum Buffet Meal. Obes Surg. 2017 Oct;27(10):2599-2605. doi: 10.1007/s11695-017-2678-6.

    PubMed 28411313

Questions about this trial

What is this clinical trial studying?

A study testing Roux-en-Y gastric bypass surgery or sleeve surgery in people with Obesity, run by University of Copenhagen at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight loss (time frame: 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02070081, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in